KDM6B and Miyoshi myopathy: KDM6B recruits to the loci of genes encoding components of the MAPK signalling pathway and upregulates the expression of these genes without affecting H3K27 methylation levels, regulating the mitogen-activated protein kinase (MAPK) pathway molecules in MM cells in a demethylase-independent manner.